Genix Pharmaceuticals Corp :oration Receives Natural Product Number for Rechlor from Health Canada

Vancouver, British Columbia – Genix Prescription drugs Company (TSX-V: GENX; OTCQB: GENPF) (‘GENIX’ or the ‘Firm’) is happy to announce that it has not too long ago obtained Well being Canada registration approval and has been issued a Pure Product Quantity (NPN) for Rechlor (Renolchlor) – which aids in restoring kidney well being and kidney features naturally.

In 2020, Genix acquired the Canadian gross sales and advertising and marketing rights for Renochlor and shall be renamed ‘Rechlor’ for the aim of gross sales within the Canadian market. The NPN for Rechlor issued to Genix is 80112398 which has been accepted for distribution to sufferers, naturopathic medical doctors and pharmacies all through Canada. Rechlor is a clinically confirmed dietary complement for enchancment of renal features in sufferers affected by Persistent Renal Failure (CRF) and Persistent Kidney Illness (CKD). In accordance with the Kidney Basis of Canada, one-in-ten Canadians, or some four million individuals, endure from kidney illness which if not handled will finally result in kidney failure and the necessity for everlasting dialysis or kidney transplant. Rechlor is the first-in-class pure over-the-counter product to successfully handle each CKD and CRF with no recognized unwanted side effects or antagonistic reactions.

About Rechlor:

Protects kidneys from numerous nephrotoxins (renal toxicity) * Assists in discount of serum creatinine and blood urea ranges * Help in enchancment of glomerular filtration fee * A novel remedy for renal care * A dietary complement appearing as nephroprotective, antioxidant, immune booster * Medical trials recommend enchancment of high quality of life in CRF sufferers

Contact:

Kevin Bottomley

Director

Tel: +1 (604) 609.6199

E: kbottomley@genixpharm.com

Statements included on this announcement, together with statements regarding our plans, intentions and expectations, which aren’t historic in nature are meant to be, and are hereby recognized as, ‘ahead?wanting statements’. Ahead?wanting statements could also be recognized by phrases together with ‘anticipates’, ‘believes’, ‘intends’, ‘estimates’, ‘expects’ and comparable expressions. The Firm cautions readers that ahead?wanting statements, together with with out limitation these referring to the Firm’s future operations and enterprise prospects, are topic to sure dangers and uncertainties that would trigger precise outcomes to vary materially from these indicated within the ahead?wanting statements.

(C) 2021 Digital Information Publishing, supply ENP Newswire